2015 ACVIM Forum Research Abstract Program

In conclusion the data shown are in accordance with other studies, showing antiepileptic properties of a MCTD, and pro-vides evidence for the implications of the MCTD as a therapeutic option for treatment in epilepsy. Nutritional modification of diets for cats with chronic kidney disease (CKD) has been shown to significantly improve survival time. Therapeutic diets for the CKD cat have been modified by restricting both protein and phosphorus while supplementing omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Supplementation with dietary omega-3 fatty acids has been shown to be beneficial in dogs but direct evidence in the cat is lacking. Omega-3 fatty acid deficiency is documented in humans with CKD but omega-3 fatty acid status is unknown in cats with CKD. The purpose of this study was to evaluate serum fatty acids in cats with CKD.